Human Microbiome Market - Global Forecast 2026-2032

The human microbiome market presents distinct opportunities and rising complexity for senior decision-makers, as scientific advances intersect with shifting regulatory environments and evolving commercialization strategies. Stakeholders tasked with investment oversight, R&D direction, and global market expansion will find actionable insights critical in positioning for sustained growth.

Market Snapshot: Human Microbiome Market Growth Trajectory

The human microbiome market expanded from USD 2.41 billion in 2025 to USD 2.98 billion in 2026, set to achieve a compound annual growth rate (CAGR) of 24.83% and reach USD 11.40 billion by 2032. This robust trajectory is shaped by increasing investments, technology adoption, and growing demand for advanced diagnostics, therapeutics, and precision wellness solutions based on microbiome science. Sector-wide transformation reflects deeper integration of microbiome research into clinical, pharmaceutical, and consumer segments, with each domain pursuing differentiated value propositions as innovation accelerates.

Scope & Segmentation of the Human Microbiome Market

Product Types: Antibiotics, live microbial supplements, advanced diagnostic devices, prebiotics—such as inulin-based and oligosaccharide formulations—and therapeutic solutions targeting specific microbiome profiles.
Microbiome Sites: Gut, oral cavity, nasal and respiratory tracts, skin, and vaginal ecosystems. Each area enables unique discovery and product development pathways, with research emphasizing respective clinical opportunities.
Application Areas: Diagnostics using microbiome sequencing or PCR pathogen detection, clinical assessments, companion diagnostics, supplements for gastrointestinal and metabolic support, and therapies aimed at dermatological or infectious conditions.
End Users: Diagnostic laboratories, home care with point-of-care technologies, hospitals, clinics, biopharmaceutical R&D, and research institutes actively driving foundational science and translational applications.
Regional Coverage: Americas, Europe, Middle East & Africa, and Asia Pacific, with each region displaying distinct regulatory, financial, and innovation landscapes influencing go-to-market strategies.
Key Technologies: High-throughput sequencing, integration of multi-omics, artificial intelligence, machine learning, and sophisticated bioinformatics platforms, supporting workflow optimization and enhanced data-driven discovery.

Key Takeaways for Senior Decision-Makers

Expanding the use of sequencing, AI, and machine learning accelerates biomarker discovery and helps to enable earlier identification of disease through in-depth microbial analysis.
Adaptive regulatory developments deliver clearer guidelines for commercialization, focusing on live biotherapeutics, companion diagnostics, and patient data privacy, helped by more investor-friendly frameworks.
Collaborative alliances between pharmaceutical firms, diagnostics developers, and academic institutions stimulate innovation and expand access to integrated diagnostics and tailored therapeutics.
Rising consumer interest in gut health, targeted nutrition, and personalized prebiotic or synbiotic products is strengthening the commercial incentive for clinically validated offerings and shaping downstream supply and distribution.
Market entry and expansion approaches must adapt for regional variation: North America leverages streamlined approvals and established public-private investment; Europe and the Middle East & Africa navigate complex regulatory frameworks; Asia Pacific benefits from strong demographic trends and expanding research networks.
Supply chain management increasingly centers on agility, with localized manufacturing, real-time inventory adaptation, and advanced digital systems considered critical for operational resilience amid external challenges.

Tariff Impact on Microbiome Supply Chains

The 2025 US tariff on key biotechnology inputs has driven shifts in microbiome supply chain management. Manufacturers and diagnostics developers have responded by locking in long-term supplier agreements and enlarging domestic warehousing to control costs and reduce sourcing delays. These strategies prioritize onshore production capacity, emphasized through collaborative public-private ventures, supporting reliable workflows despite ongoing market and geopolitical uncertainty.

Methodology & Data Sources

This report synthesizes primary interviews conducted with industry executives, technical specialists, and scientific researchers across diagnostic, therapeutic, and basic research sectors. Secondary information is drawn from peer-reviewed journals, regulatory documents, patent filings, and white papers. Sophisticated analyses—including scenario mapping and content analysis—ensure strategic accuracy and practical value for decision support.

Why This Report Matters

Enables leadership teams to benchmark investments, evaluate risk, and stay current on evolving global regulatory requirements in the human microbiome market.
Supports forward-looking strategy by distilling technology trends, highlighting growth alliances, and pinpointing operational barriers across the value chain.
Offers data-driven perspectives that inform research direction, facilitate regional expansion decisions, and strengthen resilient supply chain planning.

Conclusion

The human microbiome market is accelerating as technologies, regulatory policies, and partnerships evolve. This analysis guides senior stakeholders in refining organizational priorities and capitalizing on scientific innovation for tangible business outcomes.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Human Microbiome Market, by Type

8.1. Antibiotics
8.2. Diagnostic Devices
8.2.1. Microbiome Sequencing Devices
8.2.2. PCR-Based Diagnostics
8.3. Prebiotics
8.3.1. Inulin
8.3.2. Oligosaccharides
8.4. Probiotics
8.5. Synbiotics

9. Human Microbiome Market, by Target Microbiome Site

9.1. Gut Microbiome
9.2. Nasal & Respiratory Microbiome
9.3. Oral Microbiome
9.4. Skin Microbiome
9.5. Vaginal Microbiome

10. Human Microbiome Market, by Application

10.1. Diagnostics
10.1.1. Biomarker Discovery
10.1.2. Clinical Diagnostics
10.1.3. Companion Diagnostics
10.2. Supplements
10.3. Therapeutics
10.3.1. Gastrointestinal Disorders
10.3.2. Infections
10.3.3. Metabolic Disorders
10.3.4. Skin Disorders

11. Human Microbiome Market, by End User

11.1. Diagnostic Laboratories
11.2. Home Care Settings
11.3. Hospitals & Clinics
11.4. Pharmaceutical & Biotechnology Companies
11.5. Research Institutes

12. Human Microbiome Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Human Microbiome Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Human Microbiome Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Human Microbiome Market
16. China Human Microbiome Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AOBiome, LLC
17.6. Axial Therapeutics, Inc.
17.7. BioHM Health Inc.
17.8. BiomeSense, Inc.
17.9. DuPont de Nemours, Inc.
17.10. Enterome Bioscience
17.11. Ferring B.V.
17.12. Finch Therapeutics Group, Inc.
17.13. Illumina, Inc.
17.14. Infinant Health Inc.
17.15. Intralytix, Inc.
17.16. Merck KGaA
17.17. Metabiomics Corporation
17.18. Osel Inc.
17.19. Pendulum Therapeutics
17.20. Synlogic, Inc.
17.21. Synthetic Biologics, Inc.
17.22. Viome Life Sciences, Inc.
17.23. Yakult Honsha Co., Ltd.

List of Figures

FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PCR-BASED DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PCR-BASED DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PCR-BASED DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SYNBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SYNBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SYNBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GUT MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GUT MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GUT MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY NASAL & RESPIRATORY MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY NASAL & RESPIRATORY MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY NASAL & RESPIRATORY MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ORAL MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ORAL MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ORAL MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY VAGINAL MICROBIOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY VAGINAL MICROBIOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY VAGINAL MICROBIOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPANION DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPANION DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 154. AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 155. AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 156. AFRICA HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 159. AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 160. AFRICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 174. ASEAN HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GCC HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 182. GCC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 183. GCC HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 184. GCC HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 185. GCC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. GCC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 187. GCC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 188. GCC HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 200. BRICS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 201. BRICS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 202. BRICS HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 203. BRICS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 205. BRICS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 206. BRICS HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. G7 HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. G7 HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 209. G7 HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 210. G7 HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 211. G7 HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 212. G7 HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. G7 HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 214. G7 HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 215. G7 HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. NATO HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NATO HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 218. NATO HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 219. NATO HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 220. NATO HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 221. NATO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. NATO HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 223. NATO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 224. NATO HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA HUMAN MICROBIOME MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 237. CHINA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 238. CHINA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
TABLE 239. CHINA HUMAN MICROBIOME MARKET SIZE, BY TARGET MICROBIOME SITE, 2018-2032 (USD MILLION)
TABLE 240. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. CHINA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 242. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 243. CHINA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Human Microbiome market report include:

AOBiome, LLC
Astarte Medical
Axial Therapeutics, Inc.
Azitra
BioGaia AB
BioHM Health Inc.
BiomeBank
BiomeSense, Inc.
BiomX Ltd.
DuPont de Nemours, Inc.
Enterome Bioscience
Exeliom Biosciences SAS
Ferring B.V.
Finch Therapeutics Group, Inc.
Ginkgo Bioworks, Inc.
Illumina, Inc.
Infinant Health Inc.
International Flavors & Fragrances Inc.
Intralytix, Inc.
Invivo Healthcare
MaaT Pharma
Merck KGaA
Metabiomics Corporation
Metabiomics Corporation
OptiBiotix Health plc
Osel Inc.
Pendulum Therapeutics
Rebiotix Inc.
Synlogic, Inc.
Synthetic Biologics, Inc.
Theriva Biologics, Inc.
Viome Life Sciences, Inc.
Yakult Honsha Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.98 Billion
Forecasted Market Value ( USD ) by 2032	$ 11.4 Billion
Compound Annual Growth Rate	24.8%
Regions Covered	Global
No. of Companies Mentioned	34

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3501EUR$3,939USD£3,033GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3777EUR$4,249USD£3,272GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5119EUR$5,759USD£4,434GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6194EUR$6,969USD£5,366GBP

Market Snapshot: Human Microbiome Market Growth Trajectory

Scope & Segmentation of the Human Microbiome Market

Key Takeaways for Senior Decision-Makers

Tariff Impact on Microbiome Supply Chains

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031

Human Microbiome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Human Microbiome Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

Microbiome Therapeutics Market - Global Forecast 2026-2032

Human Microbiome Market - Forecasts from 2025 to 2030